Implications of Potential US FDA Approval of Psychedelics or Psychedelic-Adjacents Such as Ibogaine for Pharmacy in Japan
Paper. Raffa RB. Cureus, 13 Sep 2026.
Tags: Review, Psilocybin, MDMA, LSD, Ibogaine, Depression, Addiction.
Regulatory knock-on: what a near-term US approval of psilocybin or noribogaine would mean for Japan's narcotics scheduling and pharmacy practice
Read the original